Article
10 December 2025 - by Shir Lynn Ong, Julian Man, Jennifer O’Brien Howard, Ashlee Mouton Borcan, Erica Chan, Scott Chow, Linda Jin, George Leung, Daisuke Seki
The evolution of the US CI insurance market offers useful insights for Asia's insurers navigating increasingly complex consumer needs and market dynamics.
Article
21 August 2025 - by Wen Yee Lee, Alex Bryant, Shir Lynn Ong
Singapore’s insurers posted strong 2024 investment returns of 5.37%, but five-year results still remain below the investment cap rate of 4.25%.
Article
20 December 2024 - by Wen Yee Lee, Alex Bryant, Shir Lynn Ong
In Singapore, investment returns rebounded in 2023 after a poor 2022, when insurers endured a sharp rise in interest rates.
Article
19 December 2024 - by Clement Bonnet, Farzana Ismail, Wen Yee Lee, Erica Chan, Pingni Eng, Shir Lynn Ong, Junaidi Amin, Joshua Ho
We surveyed life and health insurers across Asia to understand the impact of high medical inflation across the region.
Article
09 October 2023 - by Wen Yee Lee, Alex Bryant, Shir Lynn Ong
Singapore par funds had very negative investment returns in 2022, but the aggregate solvency ratio remained even thanks to shareholder capital from surplus accounts.
Article
11 November 2022 - by Wen Yee Lee, Alex Bryant, Shir Lynn Ong
In this e-Alert we review the position of par funds in Singapore at the end of 2021 and compare this to the position at the end of 2020.
Article
26 October 2021 - by Wen Yee Lee, Alex Bryant, Shir Lynn Ong
This e-Alert reviews the position of participating funds in Singapore at the end of 2020, based on public information published in 2021.
Article
16 July 2018 - by Clement Bonnet, Michael Daly, Richard Holloway, Farzana Ismail, Philip Jackson, Sanket Kawatkar, Sung Hoon Kim, Takahiro Kinoshita, David Kong, Wen Yee Lee, Shir Lynn Ong, Paul Sinnott, Wing F. Wong, Sing Yee Yeoh
This research report provides a summary of Asian life insurance regulatory regimes.